Eli Lilly & Co. (LLY) Tops Q1 EPS by 9c; Reaffirms FY13 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,409.38 --0%
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.14, $0.09 better than the analyst estimate of $1.05. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.66 billion.
Eli Lilly & Co. reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Eli Lilly & Co. reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s posts better-than-expected third-quarter comparable sales
- Studio City International Holdings Limited (MSC) Reports Q3 Loss of $0.02
- Natural Resource Partners (NRP) Reports Q3 EPS of $1.95
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
